Ajanta Pharma among 5 midcap stocks to hit 52-week highs & surge up to 18% in a month

Latest fundraising values the six-year-old company at about $650mn as it aims to be ‘daily luxury brand’

Stéphane Boujnah has obsessively chased acquisitions to compete with larger rivals

As governments borrow more, the buyers of their debt are changing

Questions mount over management of mandatory pension schemes for professionals worth €300bn

Regulator says Jason Satsky helped a friend make $18.5mn in illegal profits tied to planned takeover of South Jersey Industries

Cattle futures fall after president says unnamed foreign suppliers will provide 25% discount for three months